School of Medicine
Showing 1-10 of 13 Results
-
Matthew Landry
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioCurrent research focuses on identifying the optimal diet (or diets) for chronic disease prevention and addressing the challenges of designing, implementing and reporting clinical trials that test dietary patterns. Particularly interested behavioral interventions that promote plant-forward and plant-based diets. Passionate advocator for policies that address nutrition-related health inequalities particularly in low resource settings and/or with communities experiencing health inequalities related to food insecurity and structural disparities.
-
Seolhyun Lee, MD
Clinical Scholar, Medicine - Nephrology
Postdoctoral Scholar, NephrologyBioDr. Lee is a nephrologist and Postdoctoral Research Fellow in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, Critical Care Medicine, Chest Journal, and Journal of Hospital Medicine.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Yuan-Hung Lo
Postdoctoral Scholar, Hematology
BioI am currently working on several projects to understand the control of gastrointestinal and cancer stem cell biology, especially how critical intrinsic genetic mutations and extrinsic extracellular components within the microenvironment influence cell behaviors. Stem cells of the gastrointestinal tract give rise to the surface lining of the epithelium, and must continuously produce new cells to replace those shed into the lumen throughout the lifespan. When mutations accumulate in these stem cells, they can grow uncontrollably into benign polyps or malignant tumors. In Dr. Calvin Kuo’s laboratory, I have used transgenic mice and primary human organoids as the models. Human organoids provide a robust primary culture system to recapitulate 3D structure and multilineage differentiation, which represents an underutilized method for the study of stem cell and cancer biology (Lo et al, Nature Cancer 2020). I have focused my efforts on establishing next generation CRISPR/Cas9 genome editing tools in primary human organoids, and applying this powerful system to gain insight into how different signaling pathways can contribute to gastrointestinal stem cell activity and tumorigenesis (Lo et al, Cancer Discovery 2021).
